Skip to main content
. 2023 Nov 30;2023:6659212. doi: 10.1155/2023/6659212

Table 1.

Mutations resulting in M. tuberculosis antimicrobial resistance [36, 57].

WHO category Resistant genes Anti-TB drug or drug class
First-line agents rpoB Rifampicin
ponA1
katG Rifampicin
Isoniazid
inhA Ethionamide
Isoniazid
oxyR-ahpC
dfrA
ahpC
kasA
furA-katG
pncA Pyrazinamide
panD
rpsA
embCAB operon Ethambutol
ubiA

Group A gyrA/B Fluoroquinolones
atpE Bedaquiline
pepQ
Rev0778
Rrl Linezolid
rplC

Group B Rv0678 BRD-9327
Rv0678 Clofazimine
pepQ
Rv1979
Rv2535c
ndh
Ald Cycloserine, terizidone
alr
ddl
cycA

Group C ddn Delamanid, pretomanid
fgd1
fbiA/B/C
crfA Imipenem/cilastatin
rrs Streptomycin
rpsl
rrs
gidB

Group C ethA Ethionamide, prothionamide
ethR
mshA
ndh
inhA
folC Para-aminosalicyclic acid (PAS)
dfrA
thyA/X
ribD

Other medicines Eis Kanamycin
tlyA Capreomycin
rrl Aminoglycosides
embB Ethambutol